GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » EBITDA Margin %

TaiwanJ Pharmaceuticals Co (ROCO:6549) EBITDA Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. TaiwanJ Pharmaceuticals Co's EBITDA for the six months ended in Dec. 2023 was NT$-17.00 Mil. TaiwanJ Pharmaceuticals Co's Revenue for the six months ended in Dec. 2023 was NT$0.00 Mil. Therefore, TaiwanJ Pharmaceuticals Co's EBITDA margin for the quarter that ended in Dec. 2023 was 0.00%.


TaiwanJ Pharmaceuticals Co EBITDA Margin % Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiwanJ Pharmaceuticals Co EBITDA Margin % Chart

TaiwanJ Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.32 - -41.47 -104.15 -7.64

TaiwanJ Pharmaceuticals Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,371.80 - -45.71 67.13 -

Competitive Comparison of TaiwanJ Pharmaceuticals Co's EBITDA Margin %

For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TaiwanJ Pharmaceuticals Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where TaiwanJ Pharmaceuticals Co's EBITDA Margin % falls into.



TaiwanJ Pharmaceuticals Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

TaiwanJ Pharmaceuticals Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1.737/22.742
=-7.64 %

TaiwanJ Pharmaceuticals Co's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-17.003/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TaiwanJ Pharmaceuticals Co  (ROCO:6549) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


TaiwanJ Pharmaceuticals Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiwanJ Pharmaceuticals Co (ROCO:6549) Business Description

Traded in Other Exchanges
N/A
Address
Rm. D207, Number 2, Sec.2, ShengYi Road, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei, TWN, 30261
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Headlines

No Headlines